Hepatitis C rates have declined by a staggering 60% among people who inject drugs since direct acting antiviral (DAAs) cures were made available through the PBS in 2016, according to a report from the Kirby Institute at University of NSW, Sydney. The latest annual study of 53 needle and syringe programs (NSPs) which included results ...
Steep decline in HCV attributed to DAAs
By Michael Woodhead
1 Aug 2019